New Delhi: Indian companies have promised to invest $20.5 billion in the United States following the SelectUSA Investment Summit in Maryland between 3 and 6 May. The figure, driven primarily by the pharmaceutical sector, is likely to be the highest ever set of investments by Indian firms at the summit.
“I am proud to advance our goal to double the US-India bilateral trade to $500 billion by 2030. Through fair, balanced, and mutually beneficial trade, we’re attracting world-class investment to the United States and creating shared prosperity for both nations,” said Ambassador Sergio Gor at the SelectUSA kick-off reception in New Delhi, before the event in the US.
SelectUSA Annual Investment Summit is the most prominent US event on foreign business investment.
In a statement on Tuesday, Gor said, “Under President Trump’s leadership investment is flowing back into the United States at record levels! Indian companies plan to invest over $20.5 billion in various sectors including tech, manufacturing, and pharmaceuticals. This includes the 12 Indian companies who announced $1.1 billion in investments just today! These partnerships are creating REAL American jobs and building STRONGER supply chains. Proof that when the world’s largest democracies do business together, everyone wins.”
According to a factsheet published by the US Embassy in India on Wednesday, the largest chunk of the investment—around $19.1 billion—is to be made in the Indian pharmaceutical sector, “anchored” by the $11.75-billion purchase of New Jersey-based Organon & Co. by Sun Pharmaceuticals.
“Participating companies include Aurobindo Pharma Ltd, Biocon Group, Cipla Limited, Dr. Reddy’s Laboratories Ltd, Glenmark Pharmaceuticals Ltd, Granules India Ltd, Jubilant Group, Lupin Limited, Sun Pharmaceutical Industries Ltd., Piramal Pharma Ltd., and Zydus Lifesciences Limited. These investments will support manufacturing and network expansions, new greenfield facilities, and increased research and development, helping expand the supply of essential medicines, address drug shortages, and strengthen the resilience of the US healthcare supply chain,” the factsheet added.
In steel, JSW Steel has promised a $225-million modernisation of its facilities in the states of Ohio and Texas, while the Abdhudyay Group headquartered in Ahmedabad has promised $900 million across five US sites, aiming to create 1,500 American jobs.
“These announcements underscore the role of SelectUSA in connecting global investors with opportunities across the United States and demonstrate how international investment continues to drive economic growth, innovation, and workforce development in communities nationwide,” the US Embassy in New Delhi said in a statement on Wednesday.
The Indian Institute of Technology Madras Global Research Foundation plans to invest $4.5 million to establish a collaboration and research hub in California, with further plans for a location on the US East Coast, said the factsheet.
Gor had highlighted the investments in a statement on Tuesday, calling them the “largest we’ve seen” in a post on social media platform X.
US President Donald J. Trump has been focussing on bringing in investments into the US since assuming power in January 2025. Since his arrival in India earlier this year, Ambassador Gor has also been speaking at business forums in an attempt to bring Indian businesses to the US.
The US administration under Trump has had an issue with the skewed trade ties in favour of India. Last year, India’s merchandise trade surplus with the US stood at roughly $41 billion. The US has been pushing Indian companies to import from the US, while also increasing its investments across the country.
Ties between India and the US faced numerous challenges across 2025, primarily due to trade issues. The two countries were finally able to negotiate a joint framework for an interim trade deal earlier this year in February. However, weeks later the US Supreme Court struck down Trump’s power to impose tariffs under the International Emergency Economic Powers Act (IEEPA).
This has left the fate of the India-US trade deal in limbo, at least till Washington unveils its new tariff architecture, expected to be in place by July 2026. India is keen to adhere to the terms of the trade deal agreed to on the basis of the new tariff architecture.
(Edited by Nardeep Singh Dahiya)
Also Read: India-US trade deal to be signed after Trump administration decides new global ‘tariff architecture’